CN102600234A - Swertia mileensis dispersible tablet and preparation method thereof - Google Patents
Swertia mileensis dispersible tablet and preparation method thereof Download PDFInfo
- Publication number
- CN102600234A CN102600234A CN2012101076634A CN201210107663A CN102600234A CN 102600234 A CN102600234 A CN 102600234A CN 2012101076634 A CN2012101076634 A CN 2012101076634A CN 201210107663 A CN201210107663 A CN 201210107663A CN 102600234 A CN102600234 A CN 102600234A
- Authority
- CN
- China
- Prior art keywords
- dried cream
- carbon dioxide
- ground
- pressure
- separator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007919 dispersible tablet Substances 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 241000096270 Swertia leducii Species 0.000 title abstract 6
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 15
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 12
- 238000000194 supercritical-fluid extraction Methods 0.000 claims abstract description 8
- 238000001035 drying Methods 0.000 claims abstract 7
- 239000000843 powder Substances 0.000 claims description 21
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 16
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 238000000605 extraction Methods 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000741 silica gel Substances 0.000 claims description 9
- 229910002027 silica gel Inorganic materials 0.000 claims description 9
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 8
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 8
- 229930195725 Mannitol Natural products 0.000 claims description 8
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 8
- 229920002472 Starch Polymers 0.000 claims description 8
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 8
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 8
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 8
- 229960003943 hypromellose Drugs 0.000 claims description 8
- 239000008101 lactose Substances 0.000 claims description 8
- 235000019359 magnesium stearate Nutrition 0.000 claims description 8
- 239000000594 mannitol Substances 0.000 claims description 8
- 235000010355 mannitol Nutrition 0.000 claims description 8
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 8
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 8
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 239000008107 starch Substances 0.000 claims description 8
- 235000019698 starch Nutrition 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 7
- 208000006454 hepatitis Diseases 0.000 claims description 5
- 231100000283 hepatitis Toxicity 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 4
- 239000006071 cream Substances 0.000 claims 9
- 238000002156 mixing Methods 0.000 claims 6
- 206010013786 Dry skin Diseases 0.000 claims 3
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 3
- 238000004132 cross linking Methods 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 238000000227 grinding Methods 0.000 claims 3
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 3
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 3
- 238000005550 wet granulation Methods 0.000 claims 3
- 239000003826 tablet Substances 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 7
- 239000000463 material Substances 0.000 abstract 1
- 230000008092 positive effect Effects 0.000 abstract 1
- 239000008869 Qing Ye Dan Substances 0.000 description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000004480 active ingredient Substances 0.000 description 8
- 210000000232 gallbladder Anatomy 0.000 description 7
- HEYZWPRKKUGDCR-QBXMEVCASA-N Swertiamarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](C=C)[C@]2(O)CCOC(=O)C2=CO1 HEYZWPRKKUGDCR-QBXMEVCASA-N 0.000 description 5
- HEYZWPRKKUGDCR-WRMJXEAJSA-N Swertiamarin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@H]1[C@@H](C=C)[C@@]2(O)C(C(=O)OCC2)=CO1 HEYZWPRKKUGDCR-WRMJXEAJSA-N 0.000 description 5
- 229920002785 Croscarmellose sodium Polymers 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 229960001681 croscarmellose sodium Drugs 0.000 description 4
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 229960000913 crospovidone Drugs 0.000 description 3
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 3
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 3
- 239000013558 reference substance Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000000941 bile Anatomy 0.000 description 2
- 238000007449 liver function test Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
- 108010082126 Alanine transaminase Proteins 0.000 description 1
- 241001071804 Gentianaceae Species 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical group CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
技术领域 technical field
本发明涉及中药领域,具体涉及一种青叶胆分散片及其制备方法。 The invention relates to the field of traditional Chinese medicines, in particular to a Qingyedan dispersible tablet and a preparation method thereof.
背景技术 Background technique
青叶胆具有清肝利胆,清热利湿功效,用于治疗黄疸性肝炎、病毒性肝炎。现有青叶胆制剂采用传统工艺制备,存在活性成份提取不完全、有效成份含量低、崩解迟缓、疗效低等不足。 Foliage Gallbladder has the effects of clearing the liver and gallbladder, clearing heat and promoting dampness, and is used for the treatment of icteric hepatitis and viral hepatitis. The existing gallbladder preparations are prepared by traditional techniques, and there are deficiencies such as incomplete extraction of active ingredients, low content of active ingredients, slow disintegration, and low curative effect.
发明内容 Contents of the invention
本发明为克服上述不足,提供一种活性成份提取完全、有效成份含量高、崩解速度快、疗效高的青叶胆分散片及其制备方法。 In order to overcome the above disadvantages, the present invention provides a Qingyedan dispersible tablet with complete extraction of active ingredients, high content of active ingredients, fast disintegration speed and high curative effect and a preparation method thereof.
发明实施方案如下: Invention embodiment is as follows:
取青叶胆1570g,粉碎成60目粗粉,采用二氧化碳超临界萃取法提取,萃取压力20~40Mpa,萃取温度20~40℃,分离器压力10~20Mpa,分离器温度40~60℃,分离时间2~4小时,二氧化碳流量每小时20~40L,得提取液;取提取液60℃~80℃减压干燥,得干膏;取干膏加入硫酸钙80~120g,采用高能纳米冲击磨粉碎成粒径200~300nm的混合干膏粉;取混合干膏粉,微晶纤维素35~45g,交联聚乙烯吡咯烷酮35~45g,交联羧甲基纤维素钠35~45g,羟丙甲纤维素25~35g,微粉硅胶15~25g,氯化钠5~15g,甘露醇4~6g,乳糖4~6g,混合均匀,用50~70%乙醇湿法制粒,60℃~80℃干燥,外加羧甲基淀粉钠7~9g,硬脂酸镁1~3g,整粒,压成1000片,制得青叶胆分散片。 Take 1570g of Foliage gallbladder, crush it into 60 mesh coarse powder, and extract it by carbon dioxide supercritical extraction method, the extraction pressure is 20-40Mpa, the extraction temperature is 20-40°C, the separator pressure is 10-20Mpa, and the separator temperature is 40-60°C. The time is 2-4 hours, the flow rate of carbon dioxide is 20-40L per hour, and the extract is obtained; the extract is dried at 60°C-80°C under reduced pressure to obtain a dry paste; the dry paste is added with 80-120g of calcium sulfate, and crushed by a high-energy nano-impact mill Mixed dry paste powder with a particle size of 200-300nm; take the mixed dry paste powder, microcrystalline cellulose 35-45g, cross-linked polyvinylpyrrolidone 35-45g, cross-linked carmellose sodium 35-45g, hypromellose Cellulose 25-35g, micropowder silica gel 15-25g, sodium chloride 5-15g, mannitol 4-6g, lactose 4-6g, mix well, wet granulate with 50-70% ethanol, dry at 60℃~80℃, Add 7 to 9 g of sodium carboxymethyl starch and 1 to 3 g of magnesium stearate, granulate it, and press it into 1000 tablets to obtain dispersible tablets of Aoba bile.
上述实施方案所提到的原材料标准如下: The raw material standard mentioned in above-mentioned embodiment is as follows:
青叶胆:中国药典2010年版一部标准,为龙胆科植物青叶胆的干燥全草,秋季花果期采收,晒干。 Folium Folium: A Standard of the Chinese Pharmacopoeia 2010 Edition, it is the dried whole herb of the Gentianaceae plant Folium Folium, harvested in the autumn flower and fruit period, and dried in the sun.
硫酸钙:中国药典2010年版二部标准。 Calcium sulfate: Chinese Pharmacopoeia 2010 edition two standards.
微晶纤维素:中国药典2010年版二部标准。 Microcrystalline cellulose: Chinese Pharmacopoeia 2010 edition two standards.
交联聚乙烯吡咯烷酮:中国药典2010年版二部标准。 Cross-linked polyvinylpyrrolidone: Chinese Pharmacopoeia 2010 edition two standards.
交联羧甲基纤维素钠:中国药典2010年版二部标准。 Croscarmellose sodium: Chinese Pharmacopoeia 2010 edition two standards.
羟丙甲纤维素:中国药典2010年版二部标准。 Hypromellose: Chinese Pharmacopoeia 2010 edition two standards.
微粉硅胶:中国药典2010年版二部标准。 Micropowder silica gel: Chinese Pharmacopoeia 2010 edition two standards.
氯化钠:中国药典2010年版二部标准。 Sodium chloride: Chinese Pharmacopoeia 2010 edition two standards.
甘露醇:中国药典2010年版二部标准。 Mannitol: Chinese Pharmacopoeia 2010 edition two standards.
乳糖:中国药典2010年版二部标准。 Lactose: the second standard of Chinese Pharmacopoeia 2010 edition.
羧甲淀粉钠:中国药典2010年版二部标准。 Carboxymethyl starch sodium: Chinese Pharmacopoeia 2010 edition two standards.
硬脂酸镁:中国药典2010年版二部标准。 Magnesium stearate: Chinese Pharmacopoeia 2010 edition two standards.
以上青叶胆分散片所用到的原材料均可从医药公司购买得到,只要满足国家标准均可用来实施本发明方案。 The raw materials used in the above Qingyedan dispersible tablets can be purchased from pharmaceutical companies, and all can be used to implement the scheme of the present invention as long as they meet the national standards.
具体实施方式 Detailed ways
本发明的具体实施例1 Specific embodiments of the present invention 1
取青叶胆1570g,粉碎成60目粗粉,采用二氧化碳超临界萃取法提取,萃取压力20Mpa,萃取温度20℃,分离器压力10Mpa,分离器温度40℃,分离时间2小时,二氧化碳流量每小时20L,得提取液;取提取液60℃减压干燥,得干膏;取干膏加入硫酸钙80g,采用高能纳米冲击磨粉碎成粒径200~300nm的混合干膏粉;取混合干膏粉,微晶纤维素35g,交联聚乙烯吡咯烷酮35g,交联羧甲基纤维素钠35g,羟丙甲纤维素25g,微粉硅胶15g,氯化钠5g,甘露醇4g,乳糖4g,混合均匀,用50%乙醇湿法制粒,60℃干燥,外加羧甲基淀粉钠7g,硬脂酸镁1g,整粒,压成1000片,制得青叶胆分散片。 Take 1570g of Foliage gallbladder, crush it into a 60-mesh coarse powder, and use carbon dioxide supercritical extraction method to extract, the extraction pressure is 20Mpa, the extraction temperature is 20°C, the separator pressure is 10Mpa, the separator temperature is 40°C, the separation time is 2 hours, and the flow of carbon dioxide per hour 20L to obtain the extract; take the extract and dry it under reduced pressure at 60°C to obtain a dry paste; add 80g of calcium sulfate to the dry paste, and use a high-energy nano-impact mill to pulverize it into a mixed dry paste powder with a particle size of 200-300nm; take the mixed dry paste powder , microcrystalline cellulose 35g, crospovidone 35g, croscarmellose sodium 35g, hypromellose 25g, micropowder silica gel 15g, sodium chloride 5g, mannitol 4g, lactose 4g, mix well, Wet granulate with 50% ethanol, dry at 60°C, add 7g of sodium carboxymethyl starch, 1g of magnesium stearate, granulate, press into 1000 pieces, and make Aoba dispersible tablets.
本发明的具体实施例2 Specific embodiment of the present invention 2
取青叶胆1570g,粉碎成60目粗粉,采用二氧化碳超临界萃取法提取,萃取压力40Mpa,萃取温度40℃,分离器压力20Mpa,分离器温度60℃,分离时间4小时,二氧化碳流量每小时40L,得提取液;取提取液80℃减压干燥,得干膏;取干膏加入硫酸钙120g,采用高能纳米冲击磨粉碎成粒径200~300nm的混合干膏粉;取混合干膏粉,微晶纤维素45g,交联聚乙烯吡咯烷酮45g,交联羧甲基纤维素钠45g,羟丙甲纤维素35g,微粉硅胶25g,氯化钠15g,甘露醇6g,乳糖6g,混合均匀,用70%乙醇湿法制粒,80℃干燥,外加羧甲基淀粉钠9g,硬脂酸镁3g,整粒,压成1000片,制得青叶胆分散片。 Take 1570g of Foliage gallbladder, crush it into 60 mesh coarse powder, and extract it by carbon dioxide supercritical extraction method, the extraction pressure is 40Mpa, the extraction temperature is 40°C, the separator pressure is 20Mpa, the separator temperature is 60°C, the separation time is 4 hours, and the flow rate of carbon dioxide per hour 40L to obtain the extract; take the extract and dry it under reduced pressure at 80°C to obtain a dry paste; add 120g of calcium sulfate to the dry paste, and use a high-energy nano-impact mill to pulverize it into a mixed dry paste powder with a particle size of 200-300nm; take the mixed dry paste powder , microcrystalline cellulose 45g, crospovidone 45g, croscarmellose sodium 45g, hypromellose 35g, micropowder silica gel 25g, sodium chloride 15g, mannitol 6g, lactose 6g, mix well, Wet granulate with 70% ethanol, dry at 80°C, add 9g of sodium carboxymethyl starch, 3g of magnesium stearate, granulate, press into 1000 pieces, and make Aoba bile dispersible tablets.
本发明的具体实施例3 Specific embodiment of the present invention 3
取青叶胆1570g,粉碎成60目粗粉,采用二氧化碳超临界萃取法提取,萃取压力30Mpa,萃取温度30℃,分离器压力15Mpa,分离器温度50℃,分离时间3小时,二氧化碳流量每小时30L,得提取液;取提取液70℃减压干燥,得干膏;取干膏加入硫酸钙100g,采用高能纳米冲击磨粉碎成粒径200~300nm的混合干膏粉;取混合干膏粉,微晶纤维素40g,交联聚乙烯吡咯烷酮40g,交联羧甲基纤维素钠40g,羟丙甲纤维素30g,微粉硅胶20g,氯化钠20g,甘露醇5g,乳糖5g,混合均匀,用60%乙醇湿法制粒,70℃干燥,外加羧甲基淀粉钠8g,硬脂酸镁2g,整粒,压成1000片,制得青叶胆分散片。 Take 1570g of Foliage gallbladder, crush it into 60 mesh coarse powder, and use carbon dioxide supercritical extraction method to extract, the extraction pressure is 30Mpa, the extraction temperature is 30°C, the separator pressure is 15Mpa, the separator temperature is 50°C, the separation time is 3 hours, and the flow rate of carbon dioxide per hour 30L to obtain the extract; take the extract and dry it under reduced pressure at 70°C to obtain a dry paste; add 100g of calcium sulfate to the dry paste, and use a high-energy nano-impact mill to pulverize it into a mixed dry paste powder with a particle size of 200-300nm; take the mixed dry paste powder , microcrystalline cellulose 40g, crospovidone 40g, croscarmellose sodium 40g, hypromellose 30g, micropowder silica gel 20g, sodium chloride 20g, mannitol 5g, lactose 5g, mix well, Wet granulate with 60% ethanol, dry at 70°C, add 8g of sodium carboxymethyl starch, 2g of magnesium stearate, granulate, press into 1000 pieces, and make Aoba dispersible tablets.
以上实施例说明,采用本发明实施方案的极端条件和优化条件均能制成青叶胆分散片。下面以实施例3制得的青叶胆分散片考察本发明的实际效果: The above examples illustrate that both extreme conditions and optimized conditions of the embodiments of the present invention can be used to make Folium Folium dispersible tablets. Inspect the practical effect of the present invention below with the Folium Chinensis dispersible tablet that embodiment 3 makes:
青叶胆分散片与青叶胆片有效成份含量对比 Comparison of active ingredient content between Qingyedan dispersible tablets and Qingyedan tablets
1 测定方法 1 Determination method
取本品青叶胆分散片或青叶胆片5g,研细,精密称定,置100ml量瓶中,加甲醇80ml,浸泡20分钟,超声处理(功率250W,频率33kHz)15分钟,放冷,加甲醇至刻度,摇匀,滤过 ,取续滤液做为供试品溶液。另取獐牙菜苦苷对照品适量,精密称定,加甲醇制成每1ml含0.5mg的溶液,做为对照品溶液。以十八烷基硅烷键合硅胶为填充剂,以甲醇-0.3%甲酸溶液(25:75)为流动相,检测波长为237nm,理论板数按獐牙菜苦苷峰计算不低于2000。分别精密吸取对照品溶液与供试品溶液各10ul,注入液相色谱仪,测定,以峰面积外标法计算獐牙菜苦苷含量。 Take this product Qingyedan dispersible tablets or Qingyedan tablets 5g, grind finely, accurately weigh, put in a 100ml measuring bottle, add 80ml of methanol, soak for 20 minutes, ultrasonically treat (power 250W, frequency 33kHz) for 15 minutes, let cool , add methanol to the mark, shake well, filter, and take the subsequent filtrate as the test solution. Take another appropriate amount of swertiamarin reference substance, weigh it accurately, add methanol to make a solution containing 0.5mg per 1ml, and use it as the reference substance solution. Octadecylsilane bonded silica gel is used as filler, methanol-0.3% formic acid solution (25:75) is used as mobile phase, the detection wavelength is 237nm, and the number of theoretical plates is not less than 2000 based on the swertiamarin peak. Accurately draw 10ul each of the reference substance solution and the test solution respectively, inject them into a liquid chromatograph, measure them, and calculate the swertiamarin content with the peak area external standard method.
2 有效成分獐牙菜苦苷含量对比 2 Comparison of content of active ingredient swertiamarin
表1 青叶胆分散片和青叶胆片獐牙菜苦苷含量对比表 Table 1 Comparison of swertiamarin content in Qingyedan dispersible tablets and Qingyedan tablets
上述结果表明, 本发明制备的青叶胆分散片相对于青叶胆片具有活性成分提取完全、有效成份含量高等显著优点。 The above results show that compared with Qingyedan Tablets, Qingyedan Dispersible Tablets prepared by the present invention have significant advantages such as complete extraction of active ingredients and higher content of active ingredients.
青叶胆分散片与青叶胆片崩解时限对比 Comparison of disintegration time between Qingyedan dispersible tablets and Qingyedan tablets
1 崩解时限测定方法 1 Determination of disintegration time
按中国药典2010年版附录Ⅻ A测定。 Measured according to Appendix Ⅻ A of Chinese Pharmacopoeia 2010 edition.
2 崩解时限对比 2 Comparison of disintegration time
表2 青叶胆分散片和青叶胆片崩解时限对比表 Table 2 Comparison table of disintegration time between Qingyedan dispersible tablets and Qingyedan tablets
上述结果表明, 本发明制备的青叶胆分散片相对于青叶胆片具有崩解速度快、生物利用度高等显著优点。 The above results show that the Qingyedan dispersible tablet prepared by the present invention has significant advantages such as faster disintegration speed and higher bioavailability compared with Qingyedan tablet.
青叶胆分散片与青叶胆片治疗急性黄疸型肝炎临床疗效观察 Clinical Observation of Qingyedan Dispersed Tablets and Qingyedan Tablets in Treating Acute Jaundice Hepatitis
1 病例情况 1 case situation
统计门诊和住院病例,共观察急性黄疸型肝炎病例121例,平均年龄39岁。患者都有黄疸,黄疸指数在20~39之间患者68例,黄疸指数在40以上患者53例。121例患者谷丙转氨酶均有升高。 According to statistics of outpatient and inpatient cases, a total of 121 cases of acute icteric hepatitis were observed, with an average age of 39 years. All patients had jaundice, 68 cases had a jaundice index between 20 and 39, and 53 cases had a jaundice index above 40. All 121 patients had elevated alanine aminotransferase.
2 治疗方法 2 treatment methods
将患者随机分为两组,试验组服用青叶胆分散片,对照组服用青叶胆片。 The patients were randomly divided into two groups, the test group took Qingyedan dispersible tablets, and the control group took Qingyedan tablets.
3 疗效评定标准 3 Evaluating Criteria for Efficacy
治愈:临床症状消失,肝功能全项检查连续两次正常。 Cured: the clinical symptoms disappeared, and the liver function tests were normal for two consecutive times.
有效:临床症状基本消失,肝功能好转,有一项或两项未恢复正常。 Effective: the clinical symptoms basically disappeared, the liver function improved, and one or two did not return to normal.
无效:临床症状无改善,肝功能检查两项以上未恢复正常。 Ineffective: no improvement in clinical symptoms, and more than two liver function tests did not return to normal.
4 临床观察结果 4 Clinical observation results
表3 青叶胆分散片和青叶胆片临床疗效对比表 Table 3 Comparison table of clinical efficacy of Qingyedan dispersible tablets and Qingyedan tablets
上述临床疗效观察结果表明,本发明制备的青叶胆分散片在治疗急性黄疸型肝炎时,疗效显著高于青叶胆片,p<0.05。 The above clinical curative effect observation results show that the curative effect of Qingyedan dispersible tablet prepared by the present invention is significantly higher than that of Qingyedan tablet in the treatment of acute icteric hepatitis, p<0.05.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210107663 CN102600234B (en) | 2012-04-13 | 2012-04-13 | Swertia mileensis dispersible tablet and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210107663 CN102600234B (en) | 2012-04-13 | 2012-04-13 | Swertia mileensis dispersible tablet and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102600234A true CN102600234A (en) | 2012-07-25 |
| CN102600234B CN102600234B (en) | 2013-06-12 |
Family
ID=46518253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210107663 Expired - Fee Related CN102600234B (en) | 2012-04-13 | 2012-04-13 | Swertia mileensis dispersible tablet and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102600234B (en) |
Cited By (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102784245A (en) * | 2012-08-01 | 2012-11-21 | 李虹霖 | Erding granule and preparation method thereof |
| CN104116822A (en) * | 2014-08-16 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Liver-protecting tablet and preparation method thereof |
| CN104116797A (en) * | 2014-08-19 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Refined Guanxin tablet and preparation method thereof |
| CN104116909A (en) * | 2014-08-16 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Tablet for quenching thirst and preparation method thereof |
| CN104116974A (en) * | 2014-08-17 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Euphorbia humifusa tablet and preparation method thereof |
| CN104117004A (en) * | 2014-08-17 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Stomach harmonizing and pain relieving capsule and preparation method thereof |
| CN104116780A (en) * | 2014-08-16 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Compound salviae miltiorrhizae tablet and preparation method thereof |
| CN104116783A (en) * | 2014-08-17 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Senecio scandens and piper cubeba rhinitis tablet and preparation method thereof |
| CN104116827A (en) * | 2014-08-19 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Yankening tablet and preparation method thereof |
| CN104116785A (en) * | 2014-08-16 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Honeysuckle and scutellaria baicalensis capsule and preparation method thereof |
| CN104117054A (en) * | 2014-08-16 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Medicated leaven capsule for stomachache and preparation method thereof |
| CN104116937A (en) * | 2014-08-16 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Fargelin tablets and preparation method thereof |
| CN104116770A (en) * | 2014-08-17 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Fengshiding capsule and preparation method thereof |
| CN104127828A (en) * | 2014-08-19 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Guangmaining tablet and preparation method thereof |
| CN104127674A (en) * | 2014-08-17 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Mind-relief tablet and preparation method thereof |
| CN104127501A (en) * | 2014-08-16 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Quick-acting anti-inflammation capsule and preparation method thereof |
| CN104127511A (en) * | 2014-08-17 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Compound Dantong tablet and preparation method thereof |
| CN104127609A (en) * | 2014-08-16 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Inflammation-resolving gall-bladder-excreting tablet and preparation method thereof |
| CN104127673A (en) * | 2014-08-16 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Zhiling capsule and preparation method thereof |
| CN104127587A (en) * | 2014-08-17 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Anti-cervicitis dispersible tablet and preparation method thereof |
| CN104127489A (en) * | 2014-08-16 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Naoluotong capsule and preparation method thereof |
| CN104138563A (en) * | 2014-08-16 | 2014-11-12 | 黑龙江江恒医药科技有限公司 | Anzhong tablet and preparation method thereof |
| CN104147278A (en) * | 2014-08-16 | 2014-11-19 | 黑龙江江恒医药科技有限公司 | Xiaohuoluo tablet and preparation method thereof |
| CN104147259A (en) * | 2014-08-17 | 2014-11-19 | 黑龙江江恒医药科技有限公司 | Zhisuning tablet and preparation method thereof |
| CN104147192A (en) * | 2014-08-16 | 2014-11-19 | 黑龙江江恒医药科技有限公司 | Naodesheng tablet and preparation method thereof |
| CN104147099A (en) * | 2014-08-16 | 2014-11-19 | 黑龙江江恒医药科技有限公司 | Coronary artery-dredging tablet and preparation method thereof |
| CN104173443A (en) * | 2014-08-16 | 2014-12-03 | 黑龙江江恒医药科技有限公司 | Liver invigorating tablet and preparation method thereof |
| CN104173629A (en) * | 2014-08-16 | 2014-12-03 | 黑龙江江恒医药科技有限公司 | Anti-lumbago tablet and preparation method thereof |
| CN104173601A (en) * | 2014-08-20 | 2014-12-03 | 赵燕翼 | Radix isatidis and folium isatidis tablet and preparation method thereof |
| CN104173828A (en) * | 2014-08-17 | 2014-12-03 | 黑龙江江恒医药科技有限公司 | Heart-calming capsule and preparation method thereof |
| CN104173561A (en) * | 2014-08-16 | 2014-12-03 | 黑龙江江恒医药科技有限公司 | Cinnabar nerve-calming tablet and preparation method thereof |
| CN104189049A (en) * | 2014-08-16 | 2014-12-10 | 黑龙江江恒医药科技有限公司 | Zhenju hypotensive tablet and preparation method thereof |
| CN104208573A (en) * | 2014-08-16 | 2014-12-17 | 黑龙江江恒医药科技有限公司 | Cholagogic and lithagogue tablet and preparation method thereof |
| CN104225383A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Hepatitis B detoxicating capsule and preparation method thereof |
| CN104225003A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Eucommia ulmoides bone-strengthening capsule and preparation method thereof |
| CN104225459A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Oxyhepatitis jaundice-removing capsule and preparation method thereof |
| CN104224956A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Mind-calming tablet and preparation method thereof |
| CN104224934A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Rhizoma corydalis pain-relieving capsule and preparation method thereof |
| CN104225046A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Hyperostosis-resistant tablet and preparation method thereof |
| CN104225359A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Jiangtangjia tablet and preparation method thereof |
| CN104224945A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Hepatitis B body-resistance-strengthening capsule and preparation method thereof |
| CN104474167A (en) * | 2014-11-30 | 2015-04-01 | 黑龙江江恒医药科技有限公司 | Jiuerxin capsules and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1853669A (en) * | 2005-04-26 | 2006-11-01 | 北京济通天宇科技有限公司 | Swertia milleensis general glycoside drip balls and preparation thereof |
| CN1857391A (en) * | 2006-04-10 | 2006-11-08 | 北京科信必成医药科技发展有限公司 | Preparing method and product of mile swertia herb dripping pill |
| CN101919919A (en) * | 2009-06-09 | 2010-12-22 | 张嵩 | Fukean dispersible tablet and preparation method thereof |
| CN102406827A (en) * | 2010-11-25 | 2012-04-11 | 中国人民解放军第四军医大学 | Pharyngitis chewable tablet and forming process |
-
2012
- 2012-04-13 CN CN 201210107663 patent/CN102600234B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1853669A (en) * | 2005-04-26 | 2006-11-01 | 北京济通天宇科技有限公司 | Swertia milleensis general glycoside drip balls and preparation thereof |
| CN1857391A (en) * | 2006-04-10 | 2006-11-08 | 北京科信必成医药科技发展有限公司 | Preparing method and product of mile swertia herb dripping pill |
| CN101919919A (en) * | 2009-06-09 | 2010-12-22 | 张嵩 | Fukean dispersible tablet and preparation method thereof |
| CN102406827A (en) * | 2010-11-25 | 2012-04-11 | 中国人民解放军第四军医大学 | Pharyngitis chewable tablet and forming process |
Non-Patent Citations (1)
| Title |
|---|
| 朱文军等: "缩短尼群地平片崩解时间的工艺优化", 《中国药业》 * |
Cited By (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102784245A (en) * | 2012-08-01 | 2012-11-21 | 李虹霖 | Erding granule and preparation method thereof |
| CN102784245B (en) * | 2012-08-01 | 2014-03-12 | 李虹霖 | Traditional Chinese medicine for treating symptom of fire-heat and toxic and preparation method thereof |
| CN104138563A (en) * | 2014-08-16 | 2014-11-12 | 黑龙江江恒医药科技有限公司 | Anzhong tablet and preparation method thereof |
| CN104208573A (en) * | 2014-08-16 | 2014-12-17 | 黑龙江江恒医药科技有限公司 | Cholagogic and lithagogue tablet and preparation method thereof |
| CN104224945A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Hepatitis B body-resistance-strengthening capsule and preparation method thereof |
| CN104225359A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Jiangtangjia tablet and preparation method thereof |
| CN104225046A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Hyperostosis-resistant tablet and preparation method thereof |
| CN104116780A (en) * | 2014-08-16 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Compound salviae miltiorrhizae tablet and preparation method thereof |
| CN104224934A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Rhizoma corydalis pain-relieving capsule and preparation method thereof |
| CN104224956A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Mind-calming tablet and preparation method thereof |
| CN104116785A (en) * | 2014-08-16 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Honeysuckle and scutellaria baicalensis capsule and preparation method thereof |
| CN104117054A (en) * | 2014-08-16 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Medicated leaven capsule for stomachache and preparation method thereof |
| CN104116937A (en) * | 2014-08-16 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Fargelin tablets and preparation method thereof |
| CN104225459A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Oxyhepatitis jaundice-removing capsule and preparation method thereof |
| CN104225003A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Eucommia ulmoides bone-strengthening capsule and preparation method thereof |
| CN104225383A (en) * | 2014-08-16 | 2014-12-24 | 黑龙江江恒医药科技有限公司 | Hepatitis B detoxicating capsule and preparation method thereof |
| CN104127501A (en) * | 2014-08-16 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Quick-acting anti-inflammation capsule and preparation method thereof |
| CN104116822A (en) * | 2014-08-16 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Liver-protecting tablet and preparation method thereof |
| CN104127609A (en) * | 2014-08-16 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Inflammation-resolving gall-bladder-excreting tablet and preparation method thereof |
| CN104127673A (en) * | 2014-08-16 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Zhiling capsule and preparation method thereof |
| CN104189049A (en) * | 2014-08-16 | 2014-12-10 | 黑龙江江恒医药科技有限公司 | Zhenju hypotensive tablet and preparation method thereof |
| CN104127489A (en) * | 2014-08-16 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Naoluotong capsule and preparation method thereof |
| CN104173561A (en) * | 2014-08-16 | 2014-12-03 | 黑龙江江恒医药科技有限公司 | Cinnabar nerve-calming tablet and preparation method thereof |
| CN104147278A (en) * | 2014-08-16 | 2014-11-19 | 黑龙江江恒医药科技有限公司 | Xiaohuoluo tablet and preparation method thereof |
| CN104116909A (en) * | 2014-08-16 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Tablet for quenching thirst and preparation method thereof |
| CN104147192A (en) * | 2014-08-16 | 2014-11-19 | 黑龙江江恒医药科技有限公司 | Naodesheng tablet and preparation method thereof |
| CN104147099A (en) * | 2014-08-16 | 2014-11-19 | 黑龙江江恒医药科技有限公司 | Coronary artery-dredging tablet and preparation method thereof |
| CN104173443A (en) * | 2014-08-16 | 2014-12-03 | 黑龙江江恒医药科技有限公司 | Liver invigorating tablet and preparation method thereof |
| CN104173629A (en) * | 2014-08-16 | 2014-12-03 | 黑龙江江恒医药科技有限公司 | Anti-lumbago tablet and preparation method thereof |
| CN104116783A (en) * | 2014-08-17 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Senecio scandens and piper cubeba rhinitis tablet and preparation method thereof |
| CN104117004A (en) * | 2014-08-17 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Stomach harmonizing and pain relieving capsule and preparation method thereof |
| CN104147259A (en) * | 2014-08-17 | 2014-11-19 | 黑龙江江恒医药科技有限公司 | Zhisuning tablet and preparation method thereof |
| CN104127587A (en) * | 2014-08-17 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Anti-cervicitis dispersible tablet and preparation method thereof |
| CN104127511A (en) * | 2014-08-17 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Compound Dantong tablet and preparation method thereof |
| CN104116974A (en) * | 2014-08-17 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Euphorbia humifusa tablet and preparation method thereof |
| CN104173828A (en) * | 2014-08-17 | 2014-12-03 | 黑龙江江恒医药科技有限公司 | Heart-calming capsule and preparation method thereof |
| CN104116770A (en) * | 2014-08-17 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Fengshiding capsule and preparation method thereof |
| CN104127674A (en) * | 2014-08-17 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Mind-relief tablet and preparation method thereof |
| CN104116827A (en) * | 2014-08-19 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Yankening tablet and preparation method thereof |
| CN104127828A (en) * | 2014-08-19 | 2014-11-05 | 黑龙江江恒医药科技有限公司 | Guangmaining tablet and preparation method thereof |
| CN104116797A (en) * | 2014-08-19 | 2014-10-29 | 黑龙江江恒医药科技有限公司 | Refined Guanxin tablet and preparation method thereof |
| CN104116797B (en) * | 2014-08-19 | 2016-09-28 | 黑龙江江恒医药科技有限公司 | A kind of Jingzhi Guanxin tablet and preparation method thereof |
| CN104173601A (en) * | 2014-08-20 | 2014-12-03 | 赵燕翼 | Radix isatidis and folium isatidis tablet and preparation method thereof |
| CN104474167A (en) * | 2014-11-30 | 2015-04-01 | 黑龙江江恒医药科技有限公司 | Jiuerxin capsules and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102600234B (en) | 2013-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102600234B (en) | Swertia mileensis dispersible tablet and preparation method thereof | |
| CN102793733B (en) | Ginseng royal jelly chewable tablets and preparation method thereof | |
| CN103070910A (en) | Preparation process of astragalus superfine powder granule decoction pieces | |
| CN105616356A (en) | Peach seed-safflower Siwu granule originated from peach seed-safflower Siwu decoction, and preparation method thereof | |
| CN105012378A (en) | Licorice root formula particle preparation method | |
| CN101919919A (en) | Fukean dispersible tablet and preparation method thereof | |
| CN110721211A (en) | A kind of preparation method of Panax notoginseng formula granules | |
| CN103565752B (en) | Wind-dispelling and hair-restoring alopecia areata pellet | |
| CN102430029B (en) | A kind of nano microcapsule for six ingredients with rehmannia and preparation technology thereof | |
| CN104225046A (en) | Hyperostosis-resistant tablet and preparation method thereof | |
| CN104383037A (en) | Anti-cerebral-thrombosis tablets and preparation method thereof | |
| CN105362622A (en) | Biyanling tablet and preparation method thereof | |
| CN104173466B (en) | Compound pyrrosia leaf dispersible tablet and preparation method thereof | |
| CN104383059A (en) | Compound berberine tablet and method for preparing same | |
| CN104382995A (en) | Glabrous sarcandra herb dispersible tablet and preparation method thereof | |
| CN104055863B (en) | A kind of Rhizoma Polygoni Cuspidati breaking cellular wall preparation | |
| CN104398935A (en) | Hemorrhoid eliminating tablet and preparation method thereof | |
| CN104324087A (en) | Dragonwort pure powder ultramicro decoction piece and preparation method thereof | |
| CN104398582A (en) | Ginkgo leaf tablet and preparation method thereof | |
| CN104367613A (en) | Stranguria-treating and calculus-removing tablet and preparation method thereof | |
| CN104127609A (en) | Inflammation-resolving gall-bladder-excreting tablet and preparation method thereof | |
| CN104398547A (en) | Andrographis paniculata and nauclea officinalis containing tablet for diminishing inflammation and preparation method thereof | |
| CN105687891A (en) | Euphorbia humifusa Willd tablet and preparation method thereof | |
| CN104398577A (en) | Effective inflammation-diminishing and dysentery-inhibiting tablet and preparation method thereof | |
| CN105362344A (en) | Hongyao tablet and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20181101 Address after: 537200 Xishan Town, Guiping City, Guigang, the Guangxi Zhuang Autonomous Region, No. 122 Cheng Bei Road. Patentee after: GUIPING PRODUCTIVITY PROMOTION CENTER Address before: 154007 School of pharmacy, D School of Jiamusi University, No. 148 Xuefu Road, Jiamusi, Heilongjiang Patentee before: Sun Changhai |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130612 |


